Mirum Pharmaceuticals, Inc.
Ticker: 1759425
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 176.24+10.2% | 159.88+20.2% | 133.01+4.1% | 127.79+14.5% | 111.59+23.5% | 90.38+16.1% | 77.88+12.5% | 69.22 |
| Total Income | 176.24+10.2% | 159.88+20.2% | 133.01+4.1% | 127.79+14.5% | 111.59+23.5% | 90.38+16.1% | 77.88+12.5% | 69.22 |
| EXPENSES | ||||||||
| Expenditure | 218.78-77.0% | 949.35+628.0% | 130.41-1.8% | 132.77+4.7% | 126.77+23.0% | 103.06+0.9% | 102.11+6.7% | 95.69 |
| Tax | 1.69+252.1% | 0.48+284.6% | -0.26-165.0% | 0.40-61.2% | 1.03+194.3% | 0.35-45.3% | 0.64+3.2% | 0.62 |
| PROFIT | ||||||||
| PBT | -65.54+91.7% | -789.68-30012.1% | 2.64+148.4% | -5.46+60.0% | -13.65+1.7% | -13.89+42.1% | -24.00+2.7% | -24.66 |
| Net Profit | -67.23+91.5% | -790.16-27253.3% | 2.91+149.7% | -5.86+60.1% | -14.68-3.1% | -14.24+42.2% | -24.64+2.5% | -25.28 |
| KEY METRICS | ||||||||
| OPM % | -24.14%+75.86pp | -100.00%-101.96pp | 1.96%+5.86pp | -3.90%+9.70pp | -13.61%+0.43pp | -14.04%+17.08pp | -31.12%+7.12pp | -38.24% |
| NPM % | -38.14%+61.85pp | -100.00%-102.18pp | 2.18%+6.77pp | -4.59%+8.57pp | -13.15%+2.60pp | -15.75%+15.89pp | -31.64%+4.88pp | -36.52% |
| EPS | -1.06+92.1% | -13.43-22483.3% | 0.06+150.0% | -0.12+60.0% | -0.30+0.0% | -0.30+42.3% | -0.52+3.7% | -0.54 |
Corporate Events
Board MeetingMIRM
202615Jun
Board Meeting
Annual Meeting of Stockholders to elect Class I directors, r…
SEC Filing ↗